Article Link: FDA Approves Orkambi (lumacaftor/ivacaftor) for Use in Children with Cystic Fibrosis Ages 6 through 11 who have Two Copies of the F508de...
FDA Approves Stelara (ustekinumab) for Treatment of Adults with Moderately to Severely Active Crohn's Disease
Article Link: FDA Approves Stelara (ustekinumab) for Treatment of Adults with Moderately to Severely Active Crohn’s Disease ...
U.S. FDA Approves Labeling Update of Rexulti (brexpiprazole) for Maintenance Treatment of Schizophrenia
Article Link: U.S. FDA Approves Labeling Update of Rexulti (brexpiprazole) for Maintenance Treatment of Schizophrenia Sourc...
FDA Approves Expanded Indications for Ilaris (canakinumab) for Three Rare Periodic Fever Syndromes
Article Link: FDA Approves Expanded Indications for Ilaris (canakinumab) for Three Rare Periodic Fever Syndromes Source: FD...